#depression #mentalhealth #drugdevelopment #antidepressant #MajorDepressiveDisorder #MDD #BeckleyPsytech #psychedelics #licensedmedicines #ELE101 #clinicaltrial #Phase2astudy #IVformulation #psilocinbenzoate #MDDpatients #MADRSscores #rapidactingMDDtreatment
pharmatimes.com/news/beckley...
pharmatimes.com/news/beckley...
Beckley Psytech announces positive results for ELE-101 in depression trial - PharmaTimes
Phase 2a study shows promising antidepressant effects
pharmatimes.com
December 17, 2024 at 12:55 PM